N/A
Completed N=61
The Effectiveness of TECH: Tablet Enhancement of Cognition and Health
Source: ClinicalTrials.gov NCT02955277 ↗Enrolled (actual)
61
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcomePrimary: The Montreal Cognitive Assessment (MoCA) — 22.6; 22.3; 23.1; 21.9 units on a scale
Summary
This study assess the effectiveness of novel cognitive intervention utilizing tablet apps (TECH protocol: Tablet Enhancement of Cognition and Health) to improve cognitive abilities, daily function and health-related quality of life of older adults with MCI. Older adults with MCI will be randomly allocated to the TECH protocol (experimental group) or standard care (control group). Assessments will be administered pre and post the 6-week TECH protocol and at 6-month follow-up by assessors blind to group allocation.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Montreal Cognitive Assessment (MoCA) |
22.6; 22.3; 23.1; 21.9; 23.3; 21.5 | — |
| SECONDARY WebNeuro |
-0.6; -0.9; -0.7; -0.9; -0.7; -0.7 | — |
| SECONDARY General Self-Efficacy Scale |
35.0; 35.0; 34.5; 33.0; 35.0; 34.0 | — |
| SECONDARY The 12-Item Short Form Health Survey (SF-12) |
29.5; 29.5; 29.5; 29.5; 29.5; 29.5 | — |
Eligibility Criteria
Inclusion Criteria
- Aged 65 and above.
- Have MCI (as determined by the following four criterions: A. a score of 19-25 on the MoCA, B. subjective memory complaints, and report from an informant of the same memory complains (the informant should be a person who interacts with the participant three or more times a week), C. Informant report of the cognitive decline as newly acquired, D. independence in Basic Activities of Daily Living (BADL) and Instrumental Activities of Daily Living (IADL), as reported by the participants and the informant, excluding motor difficulties which are not caused due to neurological conditions or lack of performance with no changes compared to the past.
- Have normal or corrected vision and hearing.
- Speak, write and read Hebrew.
- Able to understand and follow use of the touchscreen of a tablet after initial demonstration.
Exclusion Criteria
- Experience severe depressive symptoms (10 points or more in The Geriatric Depression Scale)
- Are diagnosed with dementia, or other neurological or psychiatric condition (such as stroke, Parkinson's disease).
Data sourced from ClinicalTrials.gov (NCT02955277). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.